. Figure S1 . Co-application of piperonyl butoxide (PBO) with fatty acid compounds.
. Figure S1 . Co-application of piperonyl butoxide (PBO) with fatty acid compounds. (A) Decanoic acid was tested for one dose (LD15 = 90 ng) and co-applied with 100 ng of PBO (which correspond to LD15 as well). Despite a visible knockdown effect (not statistically significant) of co-applied decanoic acid and PBO after 1 and 4 hours, there was no significant synergistic effect on mortality at 24 hours. (B) For 5-HDC, the probit analyses (curves) were calculated from a range of tested doses (colored symbols, experimental values). The slopes and LD50 values have been determined, and are reported in Table S1 . For 5-HDC alone, LD50 = 2.6 µg; for co-applied 5-HDC/PBO, LD50 = 1.0 µg. But the 95% confidence intervals overlap extensively, which means no significant difference between topical application with or without PBO. 
